Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Cara’s Partnership With Vifor Fresenius Provides Validation For Pruritis Drug Korsuva

May 23 2018

• By Joseph Haas

business

Related Content

Trevi Therapeutics Goes Up Against Cara In Itch

Sep 15 2015

Galenica and Fresenius form new renal-focused firm

Dec 03 2010

Cara Ready To Move Into Pivotal Studies In ESRD Pruritus

Oct 16 2017

Related Companies

Cara Therapeutics, Inc.

CSL Vifor

Fresenius SE & Co. KGaA

Trevi Therapeutics, Inc.

CSL Vifor

Maruishi Pharmaceutical Co., Ltd.

Chong Kun Dang Pharmaceutical Corp.

Additional Topics

Deals Commercial Business Strategies Renal BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.